LYTIX BIOPHARMA AS
LYTIX
6,70 NOK
-0,30 (↓ 4,29%)
- Tid15:30
- Markedsverdi268,46 mill.
- Kjøp6,20
- Selg7,30
- Høy6,70
- Lav6,50
- Volum15 949,00
- Omsetning104 244,28
Dag
Uke
Mnd
YTD
År
3 år
5 år
10 år
Ordredybde
| Volum | Kjøp | Selg | Volum | |
|---|---|---|---|---|
| 50 | 6,20 | 7,30 | 79 | |
| 720 | 6,02 | 7,40 | 1 000 | |
| 320 | 5,68 | 8,10 | 1 000 | |
| 320 | 5,68 | 9,00 | 2 000 | |
| 500 | 5,56 | 8,78 | 2 618 |
Børsmeldinger
09. feb 202307:00
Lytix Biopharma: Invitation to presentation of fourth quarter and second half 2022 results, Thursday 16 February →15. des 202214:08
Finansiell kalender →15. des 202214:08
Financial calendar →14. des 202218:15
Lytix Biopharma AS: GRANT OF SHARE OPTIONS →17. nov 202207:00
Lytix Biopharma third quarter 2022 results →10. nov 202213:00
Lytix Biopharma presents compelling data in collaboration with research groups at National Cancer Institute and Weill Cornell Medicine, USA. →10. nov 202207:00
Lytix Biopharma: Invitation to presentation of third quarter 2022 results, Thursday 17 November →01. nov 202214:25
Invitation to Capital Markets Day in Oslo, November 22, 2022 →Finanskalender
DatoHendelse
29. marÅrsrapport
17. aprOrdinær generalforsamling
10. maiKvartalsrapport - Q1
30. augHalvårsrapport
15. novKvartalsrapport - Q3
Største eiere
EierAndel
TAJ HOLDING AS
13,58%
CITIBANK, N.A.
9,21%
JAKOB HATTELAND HOLDING AS
7,49%
NORTH MURRAY AS
7,41%
WAATVIKA AS
4,51%
BRØDRENE KARLSEN HOLDING AS
4,27%
CARE HOLDING AS
3,02%
PICASSO KAPITAL AS
2,80%
PER STRAND EIENDOM AS
2,56%
SKANDINAVISKA ENSKILDA BANKEN AB
2,17%
Andre
42,99%